Baxalta | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (28)

View All

Latest Posts

About This Stock More About This Stock
Baxalta Cancels Partnership Deal With Onconova Therapeutics
Article By: Terry Chrisomalis
Friday, March 4, 2016 4:55 PM EDT
Baxalta backs out of deal for rigosertib despite ongoing clinical trials, effective August 30.
In this article: BXLT, ONTX Also: SHPG
Read
Baxalta - Chart Of The Day
Article By: Jim Van Meerten
Monday, January 25, 2016 9:01 PM EDT
Since the Trend Spotter signaled a buy on 1/14 the stock gained 2.22%.
In this article: BXLT
Read
Why Baxalta Is A Sell Now For Dividend Growth Investors
Article By: SureDividend
Monday, January 18, 2016 4:22 PM EDT
Baxalta stock is trading for $40 per share. Baxalta investors who purchased at the closing price on July 6th, 2015 are sitting on 27% total returns (including dividends).
In this article: BXLT
Read
View From The Hill (Jan-6-2016): Go And Expect More Pain Before Gain
Article By: Hillbent
Wednesday, January 6, 2016 11:08 AM EDT
As stated yesterday, the market internals are weak and therefore the resumed acceleration in bearish momentum was more or less expected. Today’s violation of key support levels was not a surprise either.
In this article: AMP, AN, BBY, CF, CMG, DLPH, ESV, FLS, GM, HES, IPG, PHM, RIG, SLB, SLG, SWN, URI, UTX, WMB, AVGO, BBBY, AAL, WBA, QRVO, BXLT
Read
Charles Schwab: On The Market - January 4, 2016
Article By: Marvin R Clark
Tuesday, January 5, 2016 1:42 AM EDT
The U.S. stock markets rang in the New Year with solid losses, with another series of disappointing Chinese manufacturing data and escalating tensions in the Middle East as a backdrop to resurfacing global concerns.
In this article: ACHC, SHPG, BXLT
Read
All Posts

Latest Tweets for $BXLT

No tweets yet!

PARTNER HEADLINES